VANCOUVER, British Columbia, Sept. 27, 2017 -- Chesapeake Gold Corp. ("Chesapeake" or the “Company”) (TSX-V:CKG) announces that pursuant to its Stock Option Plan, the Board of Directors has granted 790,000 options (“Options”) to directors, officers, employees and consultants of the Company, at an exercise price of $3.75 per share. The Options are exercisable for a term of five years from the date of the grant. The Options will vest and be exercisable on the basis of 25% annually commencing September 27, 2018, the first anniversary of the date of the option grant.
For more information on Chesapeake and its Metates Project, please visit our website at www.chesapeakegold.com or contact investor relations at 604-731-1094.
CHESAPEAKE GOLD CORP.
“P. Randy Reifel”
P. Randy Reifel
President
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



